Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LAA | Ann: LatAm Announces Voluntary De-Listing from ASX | 14/08/23 | 12 | 20K | |||
|
|||||||
LAA | Ann: Change in substantial holding | 13/05/20 | 3 | 1.6K | |||
|
|||||||
LAA | Ann: Change in substantial holding | 06/05/20 | 0 | 509 | |||
|
|||||||
LAA | Ann: Change in substantial holding | 06/05/20 | 0 | 526 | |||
|
|||||||
LAA | Ann: Change of Date for Removal from ASX Official List | 06/05/20 | 0 | 689 | |||
|
|||||||
LAA | Ann: Suspension and removal from official list | 05/05/20 | 0 | 597 | |||
|
|||||||
LAA | Ann: Change in substantial holding | 05/05/20 | 0 | 547 | |||
|
|||||||
LAA | Ann: Change of Director's Interest Notice | 05/05/20 | 0 | 541 | |||
|
See All Discussions